PolyPid Ltd reports results for the quarter ended in June - Earnings Summary

Polypid

14/08/2024 14:31

* PolyPid Ltd  PYPD.OQ  reported a quarterly adjusted loss
of
$1.25​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of
$-3.90.  The mean expectation of three analysts for the quarter
was for a loss of $1.30 per share. Wall Street expected
results to range from $-1.51 to $-1.19 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * PolyPid Ltd's reported EPS for the quarter was a loss of
$1.25​.
    * The company reported a quarterly loss of $6.29 million.
    * PolyPid Ltd shares had fallen by 17.2% this quarter and
lost 6.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 4.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for PolyPid Ltd is
$13.00 
This summary was machine generated from LSEG data August 14 at
01:30 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -1.30          -1.25          Beat
 Mar. 31 2024      -1.41          -1.37          Beat
 Dec. 31 2023      -3.58          -3.97          Missed
 Sep. 30 2023      -4.16          -3.40          Beat